Promising new combo tackles tough childhood cancer
NCT ID NCT03786783
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 24 times
Summary
This study tests whether adding two immunotherapy drugs (dinutuximab and sargramostim) to standard chemotherapy is safe and effective for children with high-risk neuroblastoma. About 42 children with newly diagnosed disease will receive this combination during early treatment. The goal is to see if this approach can better control the cancer and improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH-RISK NEUROBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
-
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
-
Children's National Medical Center
Washington D.C., District of Columbia, 20010, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
Primary Children's Hospital
Salt Lake City, Utah, 84113, United States
-
Royal Children's Hospital
Parkville, Victoria, 3052, Australia
-
Saint Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
Starship Children's Hospital
Grafton, Auckland, 1145, New Zealand
-
The Children's Hospital at Westmead
Westmead, New South Wales, 2145, Australia
Conditions
Explore the condition pages connected to this study.